Movement Alert｜True Health Medical-B Declines 7.89% in Regular Trading, Pullback After Massive Post-IPO Rally

Market Focus

8 hours ago

On July 3, True Health Medical-B declined 7.89% in regular trading, trading at 416.0 HKD/share, with turnover of HK$9.3575 million.

The decline comes as a technical correction following an extraordinary post-IPO surge. The company listed on the Hong Kong Stock Exchange on June 30 at an offer price of HK$126.20 per share, backed by 1,790.4 times oversubscription in the Hong Kong public offering. On its debut day, the stock closed at HK$400, representing a gain of approximately 217%. The stock continued to climb on July 2, rising over 21% intraday. The rapid accumulation of short-term gains has now triggered profit-taking pressure.

The company is engaged in the research, development, and commercialization of percutaneous puncture surgical robots and ablation surgical robots in China. Its core products hold the leading market share nationally, with 36.4% by shipment volume, and have been deployed in nearly 100 medical institutions with over 7,200 completed procedures.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1151830971"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1151830971\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1151830971?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-03 09:57","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1151830971","market":"hk","top_or_hot":-1,"title":"Movement Alert｜True Health Medical-B Declines 7.89% in Regular Trading, Pullback After Massive Post-IPO Rally","media":"Market Focus","content":"<p><p>On July 3, True Health Medical-B declined 7.89% in regular trading, trading at 416.0 HKD/share, with turnover of HK$9.3575 million.</p><p>The decline comes as a technical correction following an extraordinary post-IPO surge. The company listed on the Hong Kong Stock Exchange on June 30 at an offer price of HK$126.20 per share, backed by 1,790.4 times oversubscription in the Hong Kong public offering. On its debut day, the stock closed at HK$400, representing a gain of approximately 217%. The stock continued to climb on July 2, rising over 21% intraday. The rapid accumulation of short-term gains has now triggered profit-taking pressure.</p><p>The company is engaged in the research, development, and commercialization of percutaneous puncture surgical robots and ablation surgical robots in China. Its core products hold the leading market share nationally, with 36.4% by shipment volume, and have been deployed in nearly 100 medical institutions with over 7,200 completed procedures.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜True Health Medical-B Declines 7.89% in Regular Trading, Pullback After Massive Post-IPO Rally</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜True Health Medical-B Declines 7.89% in Regular Trading, Pullback After Massive Post-IPO Rally\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-07-03 09:57</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On July 3, True Health Medical-B declined 7.89% in regular trading, trading at 416.0 HKD/share, with turnover of HK$9.3575 million.</p><p>The decline comes as a technical correction following an extraordinary post-IPO surge. The company listed on the Hong Kong Stock Exchange on June 30 at an offer price of HK$126.20 per share, backed by 1,790.4 times oversubscription in the Hong Kong public offering. On its debut day, the stock closed at HK$400, representing a gain of approximately 217%. The stock continued to climb on July 2, rising over 21% intraday. The rapid accumulation of short-term gains has now triggered profit-taking pressure.</p><p>The company is engaged in the research, development, and commercialization of percutaneous puncture surgical robots and ablation surgical robots in China. Its core products hold the leading market share nationally, with 36.4% by shipment volume, and have been deployed in nearly 100 medical institutions with over 7,200 completed procedures.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02697","symbol_name":"真健康医疗-B","start_time":0,"source_url":"","article_id":"1151830971","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1151830971","pubTimestamp":1783043860,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On July 3, True Health Medical-B declined 7.89% in regular trading, trading at 416.0 HKD/share, with turnover of HK$9.3575 million.The decline comes as a technical correction following an...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02697":"真健康医疗-B"},"translate_title":"走势提示|真健康医疗-B常规交易下跌7.89%，IPO后大幅反弹后回调","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02697":1},"content_text":"On July 3, True Health Medical-B declined 7.89% in regular trading, trading at 416.0 HKD/share, with turnover of HK$9.3575 million.The decline comes as a technical correction following an extraordinary post-IPO surge. The company listed on the Hong Kong Stock Exchange on June 30 at an offer price of HK$126.20 per share, backed by 1,790.4 times oversubscription in the Hong Kong public offering. On its debut day, the stock closed at HK$400, representing a gain of approximately 217%. The stock continued to climb on July 2, rising over 21% intraday. The rapid accumulation of short-term gains has now triggered profit-taking pressure.The company is engaged in the research, development, and commercialization of percutaneous puncture surgical robots and ablation surgical robots in China. Its core products hold the leading market share nationally, with 36.4% by shipment volume, and have been deployed in nearly 100 medical institutions with over 7,200 completed procedures.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}